These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6331295

  • 1. Antibacterial activity of coumermycin alone and in combination with other antibiotics.
    Neu HC, Chin NX, Labthavikul P.
    Antimicrob Agents Chemother; 1984 Jun; 25(6):687-9. PubMed ID: 6331295
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of CI934, a new fluoroquinolone, alone and in combination with coumermycin, against gram-positive bacteria.
    van der Auwera P, Vandermies A, Grenier P, Klastersky J.
    Drugs Exp Clin Res; 1987 Jun; 13(3):125-32. PubMed ID: 3622241
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN, Barry AL.
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
    Hirschl AM, Georgopoulos A, Stanek G, Breyer S, Rotter ML.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
    Meyers BR, Srulevitch ES, Hirschman SZ.
    Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents.
    Thomas MG, Lang SD.
    J Antimicrob Chemother; 1986 Aug; 18(2):171-5. PubMed ID: 3639086
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
    Floyd-Reising SA, Kelley SG, Hindler JA, Young LS.
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M, Gahrn-Hansen B, Søgaard P, Bentzon MW.
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
    Chin NX, Neu HC.
    Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin.
    Gombert ME, Aulicino TM.
    Antimicrob Agents Chemother; 1984 Dec; 26(6):933-4. PubMed ID: 6570085
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
    Unowsky J, Chandrasekar PH, DeLorenzo W, Levine DP.
    Chemotherapy; 1986 Dec; 32(6):499-505. PubMed ID: 3492342
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of teichomycin compared with those of other antibiotics.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1983 Sep; 24(3):425-8. PubMed ID: 6227282
    [Abstract] [Full Text] [Related]

  • 17. Activity of coumermycin against clinical isolates of staphylococci.
    Guillemin MN, Miles HM, McDonald MI.
    Antimicrob Agents Chemother; 1986 Apr; 29(4):608-10. PubMed ID: 3707109
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
    Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):839-45. PubMed ID: 8849237
    [Abstract] [Full Text] [Related]

  • 19. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
    Van der Auwera P, Joly P.
    J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Perronne CM, Malinverni R, Glauser MP.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.